Add to Basket
|+1 404 474 4654|
|+1 888 205 9894 (TF)|
SARS (Severe Acute Respiratory Syndrome) Spike Protein (C-Term) antibody
|4 references available|
|Quantity||100ug (Lot specific)|
|Price||392.33 $ Plus shipping costs $45.00|
|Availability||Will be delivered in 4 to 5 Business Days|
|Immunogen||Synthetic peptide corresponding to amino acids at the C-terminus of the SARS Spike glycoprotein (Genbank accession no. P59594).|
|Description||Rabbit anti SARS Spike C-term. Rabbit Antibody to SARS (Severe Acute Respiratory Syndrome) Spike protein, C-terminal|
|Specificity||Reacts with the C-terminal of the spike protein of SARS-associated coronavirus. The spike protein is a glycosylated 139kDa protein and the major surface antigen of the virus.|
|Application Notes||Suitable for use in ELISA. It will detect 10ng of free peptide at 1ug/ml. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.|
|Buffer||PBS. Preservative: 0.02% Sodium Azide|
|Storage||Store (up to one year) at 2-8°C. : This product contains sodium azide, which has been classified as Xn (Harmful) in European Directive 67/548/EEC in the concentration range of 0.1-1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains.|
|Restrictions||For Research Use only|
Rota, Oberste, Monroe et al.: "Characterization of a novel coronavirus associated with severe acute respiratory syndrome." in: Science (New York, N.Y.), Vol. 300, Issue 5624, pp. 1394-9, 2003 (PubMed).
Marra, Jones, Astell et al.: "The Genome sequence of the SARS-associated coronavirus." in: Science (New York, N.Y.), Vol. 300, Issue 5624, pp. 1399-404, 2003 (PubMed).
Li, Moore, Vasilieva et al.: "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus." in: Nature, Vol. 426, Issue 6965, pp. 450-4, 2003 (PubMed).
Navas-Martín, Weiss: "Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development." in: Journal of neurovirology, Vol. 10, Issue 2, pp. 75-85, 2004 (PubMed).